XML 52 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Vibativ®, Sancuso® and RediTrex® Products (Tables)
12 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Business Acquisitions by Acquisition, Contingent Consideration
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance annually.
Contingent Consideration Liability
Balance at December 31, 2021$6,515,627 
Cash payment of royalty during the period(1,133,113)
Change in fair value(2,104,690)
Contingent consideration earned and accrued876,999 
Balance at December 31, 2022$4,154,823 
Cash payment of royalty during the period(1,018,451)
Change in fair value(270,485)
Contingent consideration earned and accrued1,167,486 
Balance at December 31, 2023$4,033,373 
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis.
Contingent Consideration LiabilityContingent Consideration Liability Including Milestone
Balance at January 3, 2022
$3,384,000 $3,946,716 
Cash payment of royalty during the period
(1,075,631)(1,075,631)
Change in fair value
16,394 1,210,678 
Contingent consideration earned and accrued
675,237 675,237 
Balance at December 31, 2022
$3,000,000 $4,757,000 
Cash payment of royalty during the period
(790,632)(2,249,632)
Change in fair value
(685,355)(983,355)
Contingent consideration earned and accrued
781,987 781,987 
Balance at December 31, 2023
$2,306,000 $2,306,000